Search Results - "Eltayb, Wafa A."

Novel Investigational Anti-SARS-CoV‑2 Agent Ensitrelvir “S-217622”: A Very Promising Potential Universal Broad-Spectrum Antiviral at the Therapeutic Frontline of Coronavirus Species by Eltayb, Wafa A., Abdalla, Mohnad, Rabie, Amgad M.

“…Lately, nitrogenous heterocyclic antivirals, such as nucleoside-like compounds, oxadiazoles, thiadiazoles, triazoles, quinolines, and isoquinolines, topped the…”
Get full text

Molecular modeling study of micro and nanocurcumin with in vitro and in vivo antibacterial validation by Othman, Amal S., Shamekh, Israa M., Abdalla, Mohnad, Eltayb, Wafa A., Ahmed, Nashwa A.

“…Repurposing natural compounds as inhibitory targets to combat bacterial virulence is an important potential strategy to overcome resistance to traditional…”
Get full text

Potent Dual Polymerase/Exonuclease Inhibitory Activities of Antioxidant Aminothiadiazoles Against the COVID-19 Omicron Virus: A Promising In Silico/In Vitro Repositioning Research Study by Rabie, Amgad M., Eltayb, Wafa A.

“…Recently, natural and synthetic nitrogenous heterocyclic antivirals topped the scene as first choices for the treatment of the severe acute respiratory…”
Get full text

Strong Dual Antipolymerase/Antiexonuclease Actions of Some Aminothiadiazole Antioxidants: A Promising In-Silico / In-Vitro Repurposing Research Study against the COVID-19 Omicron Virus (B.1.1.529.3 Lineage) by Rabie, Amgad M, Eltayb, Wafa A

“…Currently, nitrogen-containing heterocyclic virucides take the lead as top options for treating the severe acute respiratory syndrome coronavirus 2…”
Get full text

WITHDRAWN: Strong Dual Antipolymerase/Antiexonuclease Actions of Some Aminothiadiazole Antioxidants: A Promising In-Silico/In-Vitro Repurposing Research Study against the COVID-19 Omicron Virus (B.1.1.529.3 Lineage) by Rabie, Amgad M., Eltayb, Wafa A.

Get full text